The transcript correlation analysis was repeated in the MSBB data, with AD status again balanced across the APOE4 and non-carrier groups using the available MSBB disease markers (mean neuritic plaques, clinical dementia rating (CDR), and Braak stage). Here, APOE is linked to Alzheimer disease.